Subscribe to our newsletter to receive the latest product updates and special offers

Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

Last Close
Jul 19 04:00PM ET
5.78
Dollar change
-0.05
Percentage change
-0.86
%
Index- P/E25.17 EPS (ttm)0.23 Insider Own46.09% Shs Outstand57.48M Perf Week-6.92%
Market Cap332.18M Forward P/E18.06 EPS next Y0.32 Insider Trans0.00% Shs Float30.99M Perf Month14.23%
Income12.46M PEG4.20 EPS next Q0.06 Inst Own12.99% Short Float0.08% Perf Quarter13.33%
Sales149.55M P/S2.22 EPS this Y13.82% Inst Trans-2.76% Short Ratio0.99 Perf Half Y-1.70%
Book/sh4.29 P/B1.35 EPS next Y31.51% ROA3.78% Short Interest0.03M Perf Year14.23%
Cash/sh0.84 P/C6.89 EPS next 5Y6.00% ROE5.91% 52W Range4.08 - 6.53 Perf YTD-5.56%
Dividend Est.- P/FCF405.09 EPS past 5Y-21.07% ROI4.91% 52W High-11.47% Beta1.07
Dividend TTM- Quick Ratio1.98 Sales past 5Y5.73% Gross Margin40.39% 52W Low41.67% ATR (14)0.24
Dividend Ex-Date- Current Ratio4.25 EPS Y/Y TTM566.15% Oper. Margin9.20% RSI (14)57.71 Volatility3.23% 4.10%
Employees378 Debt/Eq0.04 Sales Y/Y TTM13.33% Profit Margin8.33% Recom1.00 Target Price14.00
Option/ShortYes / Yes LT Debt/Eq0.03 EPS Q/Q201.99% Payout0.00% Rel Volume1.34 Prev Close5.83
Sales Surprise-1.34% EPS Surprise-26.50% Sales Q/Q22.88% EarningsMay 08 BMO Avg Volume25.87K Price5.78
SMA206.56% SMA507.76% SMA2006.63% Trades Volume34,571 Change-0.86%
Date Action Analyst Rating Change Price Target Change
Jul-03-24Initiated Stifel Buy $18
Feb-02-18Initiated Chardan Capital Markets Buy $7
May-08-24 11:57AM
07:00AM
May-01-24 07:00AM
Mar-06-24 12:52PM
07:05AM
07:00AM Loading…
07:00AM
Feb-28-24 07:00AM
Dec-07-23 11:00AM
Dec-06-23 07:00AM
Nov-13-23 07:00AM
Nov-08-23 07:00AM
Oct-16-23 07:00AM
Oct-10-23 07:37AM
Aug-30-23 07:00AM
Aug-16-23 07:00AM
07:00AM Loading…
Aug-09-23 07:00AM
Jul-12-23 07:00AM
May-24-23 07:10AM
07:05AM
07:00AM
May-17-23 07:00AM
May-16-23 07:00AM
May-03-23 07:00AM
Mar-15-23 07:10AM
07:00AM
Mar-09-23 08:00AM
Jan-04-23 07:00AM
Dec-19-22 07:00AM
Dec-15-22 09:07AM
Dec-02-22 10:54AM
07:39AM Loading…
Nov-28-22 07:39AM
Nov-23-22 11:42AM
Nov-22-22 08:25AM
07:00AM
Nov-16-22 07:00AM
Nov-10-22 05:25PM
Nov-07-22 07:00AM
Oct-26-22 07:00AM
Oct-19-22 07:00AM
Oct-12-22 12:11PM
Sep-22-22 01:28PM
Sep-20-22 12:10PM
Sep-19-22 12:28PM
12:21PM
Sep-16-22 11:42AM
Sep-14-22 01:09PM
Sep-13-22 11:24AM
Sep-09-22 12:23PM
Aug-17-22 08:25AM
07:00AM
Aug-15-22 08:15AM
Aug-10-22 07:00AM
Jul-15-22 07:00AM
Jul-06-22 06:00AM
Jun-15-22 07:00AM
Jun-01-22 07:00AM
May-17-22 08:25AM
07:05AM
07:00AM
May-11-22 07:00AM
Mar-15-22 07:05AM
07:00AM
Mar-14-22 08:00AM
Mar-02-22 07:00AM
Nov-22-21 10:44AM
08:25AM
07:05AM
07:00AM
Nov-08-21 07:00AM
Oct-08-21 02:37AM
Oct-07-21 11:03PM
Aug-25-21 10:08AM
Aug-11-21 08:45AM
07:00AM
Aug-05-21 07:00AM
Aug-04-21 03:00PM
Jun-18-21 10:24AM
Jun-02-21 07:00AM
May-12-21 10:31AM
07:00AM
06:45AM
May-05-21 07:00AM
Apr-07-21 07:00AM
Mar-31-21 07:40AM
06:00AM
Mar-09-21 07:00AM
Mar-03-21 07:00AM
Feb-24-21 07:00AM
Feb-10-21 08:35AM
07:18AM
07:00AM
06:15AM
Feb-03-21 12:31PM
07:00AM
Feb-01-21 07:00AM
Jan-13-21 07:00AM
Jan-05-21 07:00AM
Dec-21-20 07:00AM
Dec-02-20 06:43PM
Nov-24-20 12:48PM
Kamada Ltd. is a biopharmaceutical company, which focuses on specialty plasma-derived therapeutic. It operates through the Proprietary Products and Distribution segments. The Proprietary Products segment covers the development, manufacture, and sale of plasma-derived protein therapeutics products. The Distribution segment covers the drug products in Israel, which are manufactured by third parties. The company was founded by David Tsur and Ralf Hahn on December 13, 1990 and is headquartered in Rehovot, Israel.